phase readout
saveNCT07510594: A Phase II Study of Benmelstobart + Anlotinib + Chemotherapy as First-Line Treatment for LCNEC and EP-NEC
NOT_YET_RECRUITINGupdated 1mo ago
community read0 votes
Sponsor: Tianjin Medical University Cancer Institute and Hospital. Phase: PHASE2. Conditions: Large-Cell Neuroendocrine Carcinoma of the Lung, Extrapulmonary Neuroendocrine Carcinoma
view source ↗
comments(0)
5-min edit window · permanent after that